The pharmaceutical world is seeing a remarkable shift in blood sugar treatment with the arrival of GLP-1 patches. These devices offer a seemingly more comfortable alternative to subcutaneous administrations of GLP-1 drugs, reducing the need for daily needle pricks. The technology releases the med